Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepesh Lad

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|September 12, 2022
Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial)Charanpreet Singh, Pankaj Malhotra, Aditya Jandial, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 23, 2026
Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Paraneoplastic ManifestationsCharanpreet Singh, K S Lekshmon, Arihant Jain, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 17, 2019
Intra-Abdominal Pseudotumors: A Rare Presentation of Von Willebrand Disease and its Management in Resource Constraint SettingKunwer Abhishek Ary, Veenu Singla, Kundan Mishra, et al.
Hematology (Amsterdam, Netherlands)|February 9, 2018
Danazol increases T regulatory cells in patients with aplastic anemiaHarshit Khurana, Pankaj Malhotra, Man Updesh Sachdeva, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Addition of Low Dose Nivolumab to Salvage Chemotherapy in Patients with Relapsed/Refractory Hodgkin LymphomaCharanpreet Singh, K S Lekshmon, Arihant Jain, et al.
International Journal of Dermatology|December 22, 2017
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patientsKeshavamurthy Vinay, Uday Yanamandra, Sunil Dogra, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal ImpairmentRintu Sharma, Arihant Jain, Aditya Jandial, et al.
Blood Advances|May 8, 2020
Poor tolerability to ponatinib in Indian CML patientsCharanpreet Singh, Arihant Jain, Deepesh Lad, et al.
British Journal of Haematology|February 4, 2020
Variables affecting the presence of mesenchymal stromal cells in peripheral blood and their relationship with apheresis productsAnkur Jain, Alka Khadwal, Man Updesh Singh Sachdeva, et al.
Leukemia & Lymphoma|April 1, 2026
Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myelomaRudra Narayan Swain, Deepesh Lad, Sarthak Wadhera, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|September 12, 2022
Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial)Charanpreet Singh, Pankaj Malhotra, Aditya Jandial, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|February 23, 2026
Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Paraneoplastic ManifestationsCharanpreet Singh, K S Lekshmon, Arihant Jain, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 17, 2019
Intra-Abdominal Pseudotumors: A Rare Presentation of Von Willebrand Disease and its Management in Resource Constraint SettingKunwer Abhishek Ary, Veenu Singla, Kundan Mishra, et al.
Hematology (Amsterdam, Netherlands)|February 9, 2018
Danazol increases T regulatory cells in patients with aplastic anemiaHarshit Khurana, Pankaj Malhotra, Man Updesh Sachdeva, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Addition of Low Dose Nivolumab to Salvage Chemotherapy in Patients with Relapsed/Refractory Hodgkin LymphomaCharanpreet Singh, K S Lekshmon, Arihant Jain, et al.
International Journal of Dermatology|December 22, 2017
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patientsKeshavamurthy Vinay, Uday Yanamandra, Sunil Dogra, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2022
Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal ImpairmentRintu Sharma, Arihant Jain, Aditya Jandial, et al.
Blood Advances|May 8, 2020
Poor tolerability to ponatinib in Indian CML patientsCharanpreet Singh, Arihant Jain, Deepesh Lad, et al.
British Journal of Haematology|February 4, 2020
Variables affecting the presence of mesenchymal stromal cells in peripheral blood and their relationship with apheresis productsAnkur Jain, Alka Khadwal, Man Updesh Singh Sachdeva, et al.
Leukemia & Lymphoma|April 1, 2026
Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myelomaRudra Narayan Swain, Deepesh Lad, Sarthak Wadhera, et al.
Pageof 13